Gastrodin reduces blood pressure by intervening with RAAS and PPAR γ in SHRs

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Liu, Wei ^a   Wang, Lingyan ^a   Yu, Jiahui ^a   Asare, Patrick Fordjour ^a   Zhao, Ying Qiang ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; GASTRODIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DOWN REGULATION; FOOD INTAKE; HEART FUNCTION; HEART MUSCLE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

EID: 84947483754     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/828427     Document Type: Article

References (22)

1. A. C. Simões E Silva and J. T. Flynn, "The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease," Pediatric Nephrology, vol. 27, no. 10, pp. 1835-1845, 2012.
2. H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama, "The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease," Pharmacological Reviews, vol. 59, no. 3, pp. 251-287, 2007.
3. S. Z. Duan, C. Y. Ivashchenko, M. G. Usher, and R. M. Mortensen, "PPAR-gamma in the cardiovascular system," PPA R Research, vol. 2008, Article ID 745804, 10 pages, 2008.
4. A. Sugawara, A. Uruno, K. Matsuda et al., "Efects of PPARγ agonists against vascular and renal dysfunction," Current Molecular Pharmacology, vol. 5, no. 2, pp. 248-254, 2012.
5. Q. Zhang, Y.-M. Yang, and G.-Y. Yu, "Efects of gastrodin injection on blood pressure and vasoactive substances in treatment of old patients with refractory hypertension: a randomized controlled trial," Journal of Chinese Integrative Medicine, vol. 6, no. 7, pp. 695-699, 2008.
6. C. Shu, C. Chen, D.-P. Zhang et al., "Gastrodin protects against cardiac hypertrophy and fbrosis," Molecular and Cellular Biochemistry, vol. 359, no. 1-2, pp. 9-16, 2012.
7. K. J. Livak and T. D. Schmittgen, "Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method," Methods, vol. 25, no. 4, pp. 402-408, 2001.
8. N. Li, K.-J. Wang, J.-J. Chen, and J. Zhou, "Phenolic compounds from the rhizomes of Gastrodia elata," Journal of Asian Natural Products Research, vol. 9, no. 4, pp. 373-377, 2007.
9. X.-D. Yang, J. Zhu, R. Yang, J.-P. Liu, L. Li, and H.-B. Zhang, "Phenolic constituents from the rhizomes of Gastrodia elata," Natural Product Research, vol. 21, no. 2, pp. 180-186, 2007.
10. Y.-Q. Xiao, L. Li, X.-L. You, B.-L. Bian, X.-M. Liang, and Y.-T. Wang, "A new compound from Gastrodia elata Blume," Journal of Asian Natural Products Research, vol. 4, no. 1, pp. 73-79, 2002.
11. L. M. Ojemann, W. L. Nelson, D. S. Shin, A. O. Rowe, and R. A. Buchanan, "Tian ma, an ancient Chinese herb, ofers new options for the treatment of epilepsy and other conditions," Epilepsy and Behavior, vol. 8, no. 2, pp. 376-383, 2006.
12. Y. Liu, X. Tang, J. Pei, L. Zhang, F. Liu, and K. Li, "Gastrodin interaction with human fbrinogen: anticoagulant efects and binding studies," Chemistry-A European Journal, vol. 12, no. 30, pp. 7807-7815, 2006.
13. C. R. Esther Jr., E. M. Marino, T. E. Howard et al., "The critical role of tissue angiotensin-converting enzyme as revealed by genetargeting in mice," The Journal of Clinical Investigation, vol. 99, no. 10, pp. 2375-2385, 1997.
14. S. A. Kliewer, H. E. Xu, M. H. Lambert, and T. M. Willson, "Peroxisome proliferator-activated receptors: from genes to physiology," Recent Progress in Hormone Research, vol. 56, pp. 239-263, 2001.
15. C. Marchesi and E. L. Schifrin, "Peroxisome proliferator-activated receptors and the vascular system: beyond their metabolic efects," Journal of the American Society of Hypertension, vol. 2, no. 4, pp. 227-238, 2008.
16. T. D. Giles and G. E. Sander, "Efects of thiazolidinediones on blood pressure," Current Hypertension Reports, vol. 9, no. 4, pp. 332-337, 2007.
17. P. A. Sarafdis and A. N. Lasaridis, "Actions of peroxisome proliferator-activated receptors-gamma agonists explaining a possible blood pressure-lowering efect," American Journal of Hypertension, vol. 19, no. 6, pp. 646-653, 2006.
18. J. A. Dormandy, B. Charbonnel, D. J. A. Eckland et al., "Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective piogli-tazone clinical trial in macrovascular events): a randomised controlled trial," The Lancet, vol. 366, no. 9493, pp. 1279-1289, 2005.
19. M. Schupp, M. Clemenz, R. Gineste et al., "Molecular characterization of new selective peroxisome proliferator-activated receptor γ modulators with angiotensin receptor blocking activity," Diabetes, vol. 54, no. 12, pp. 3442-3452, 2005.
20. R. A. Sanchez, L. D. Masnatta, C. Pesiney, P. Fischer, and A. J. Ramirez, "Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives," Journal of Hypertension, vol. 26, no. 12, pp. 2393-2398, 2008.
21. I. Imayama, T. Ichiki, K. Inanaga et al., "Telmisartan down-regulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor γ," Cardiovascular Research, vol. 72, no. 1, pp. 184-190, 2006.
22. E. R. Blasi, J. Heyen, M. Hemkens, A. McHarg, C. M. Ecelbarger, and S. Tiwari, "Efects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats," PPAR Research, vol. 2009, Article ID 237865, 13 pages, 2009.